Dr. Wederson Claudino, MD

NPI: 1588977391
Total Payments
$29,178
2024 Payments
$1,073
Companies
81
Transactions
871
Medicare Patients
5,684
Medicare Billing
$738,552

Payment Breakdown by Category

Food & Beverage$16,300 (55.9%)
Consulting$9,945 (34.1%)
Travel$2,086 (7.1%)
Education$822.71 (2.8%)
Gifts$25.00 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $16,300 831 55.9%
Consulting Fee $9,945 6 34.1%
Travel and Lodging $2,086 9 7.1%
Education $822.71 24 2.8%
Gift $25.00 1 0.1%

Top Paying Companies

Company Total Records Latest Year
Takeda Pharmaceuticals U.S.A., Inc. $4,144 14 $0 (2022)
AstraZeneca Pharmaceuticals LP $3,821 36 $0 (2024)
Merck Sharp & Dohme LLC $3,084 76 $0 (2024)
Janssen Biotech, Inc. $2,643 58 $0 (2023)
Amgen Inc. $2,221 35 $0 (2023)
E.R. Squibb & Sons, L.L.C. $1,454 81 $0 (2024)
Genentech USA, Inc. $896.77 45 $0 (2023)
Novartis Pharmaceuticals Corporation $813.44 49 $0 (2023)
GENZYME CORPORATION $672.08 33 $0 (2023)
Regeneron Healthcare Solutions, Inc. $639.97 18 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,073 13 E.R. Squibb & Sons, L.L.C. ($353.17)
2023 $4,211 104 Merck Sharp & Dohme LLC ($2,086)
2022 $3,555 183 Janssen Biotech, Inc. ($225.72)
2021 $2,193 120 AstraZeneca Pharmaceuticals LP ($262.11)
2020 $3,189 82 Amgen Inc. ($1,613)
2019 $6,231 97 AstraZeneca Pharmaceuticals LP ($2,812)
2018 $6,320 137 Takeda Pharmaceuticals U.S.A., Inc. ($4,018)
2017 $2,406 135 Genentech USA, Inc. ($432.56)

All Payment Transactions

871 individual payment records from CMS Open Payments — Page 1 of 35

Date Company Product Nature Form Amount Type
12/09/2024 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $2.01 General
Category: Oncology
12/09/2024 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $1.05 General
Category: Oncology
11/21/2024 AstraZeneca Pharmaceuticals LP ENHERTU (Biological) Food and Beverage In-kind items and services $126.00 General
Category: Oncology
10/23/2024 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $1.91 General
Category: Oncology
10/17/2024 PharmaEssentia USA Corporation BESREMI (Drug) Food and Beverage In-kind items and services $119.70 General
Category: Oncology
08/29/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $117.27 General
Category: ONCOLOGY
08/22/2024 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $123.84 General
08/08/2024 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $119.70 General
Category: Oncology
06/03/2024 Lilly USA, LLC Education In-kind items and services $74.59 General
05/10/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Food and Beverage In-kind items and services $129.60 General
Category: ONCOLOGY
04/11/2024 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $104.66 General
Category: Oncology
02/28/2024 Tempus AI, Inc Food and Beverage In-kind items and services $29.25 General
02/01/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $123.48 General
Category: ONCOLOGY
11/30/2023 GlaxoSmithKline, LLC. JEMPERLI (Biological) Food and Beverage In-kind items and services $50.07 General
Category: ONCOLOGY
11/17/2023 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Food and Beverage In-kind items and services $85.06 General
Category: ONCOLOGY
08/31/2023 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $138.00 General
Category: Oncology
08/30/2023 NOVARTIS PHARMACEUTICALS CORPORATION PIQRAY (Drug), KISQALI Food and Beverage In-kind items and services $16.56 General
Category: Oncology
08/29/2023 PFIZER INC. XTANDI (Drug), ORGOVYX Food and Beverage In-kind items and services $17.67 General
Category: ONCOLOGY
08/28/2023 Stemline Therapeutics Inc. Orserdu (Drug) Food and Beverage In-kind items and services $19.59 General
Category: Oncology
08/28/2023 Rigel Pharmaceuticals, Inc. Rezlidhia (Drug), Tavalisse Food and Beverage Cash or cash equivalent $11.17 General
Category: Acute Myeloid Leukemia
08/23/2023 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $11.83 General
Category: ONCOLOGY
08/22/2023 E.R. Squibb & Sons, L.L.C. OPDUALAG (Drug) Food and Beverage Cash or cash equivalent $16.11 General
Category: Oncology
08/22/2023 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $0.67 General
Category: Oncology
08/18/2023 PFIZER INC. INLYTA (Drug), XTANDI, TALZENNA Food and Beverage In-kind items and services $11.19 General
Category: ONCOLOGY
08/15/2023 Novartis Pharmaceuticals Corporation KISQALI (Drug), PIQRAY Food and Beverage In-kind items and services $26.33 General
Category: Oncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 13 1,448 2,963 $409,093 $207,436
2022 14 1,490 2,914 $390,960 $191,580
2021 13 1,407 2,532 $354,501 $184,935
2020 12 1,339 2,560 $314,133 $154,601
Total Patients
5,684
Total Services
10,969
Medicare Billing
$738,552
Procedure Codes
52

All Medicare Procedures & Services

52 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 296 963 $140,176 $69,115 49.3%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 244 816 $84,864 $48,090 56.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 229 355 $36,698 $17,941 48.9%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 123 139 $40,449 $17,837 44.1%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 99 99 $26,745 $13,196 49.3%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 113 131 $25,938 $12,625 48.7%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 81 106 $22,790 $11,298 49.6%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 90 141 $8,460 $5,097 60.3%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 30 50 $7,450 $4,486 60.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 36 36 $7,275 $3,474 47.8%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2023 44 56 $5,488 $2,679 48.8%
99443 Telephone medical discussion with physician, 21-30 minutes Office 2023 15 16 $2,320 $1,165 50.2%
36415 Insertion of needle into vein for collection of blood sample Office 2023 48 55 $440.00 $431.20 98.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 288 1,011 $148,921 $71,987 48.3%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 146 164 $47,724 $23,336 48.9%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 180 391 $40,664 $20,983 51.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 215 316 $32,768 $15,341 46.8%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 187 498 $29,880 $14,512 48.6%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 122 138 $27,324 $13,628 49.9%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 90 90 $24,552 $12,509 50.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 57 67 $14,338 $7,192 50.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 42 42 $8,512 $4,020 47.2%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 37 45 $6,705 $3,476 51.8%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2022 43 60 $5,880 $2,894 49.2%
99443 Telephone medical discussion with physician, 21-30 minutes Office 2022 14 14 $2,030 $1,047 51.6%

About Dr. Wederson Claudino, MD

Dr. Wederson Claudino, MD is a Internal Medicine healthcare provider based in Paducah, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2010. The National Provider Identifier (NPI) number assigned to this provider is 1588977391.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wederson Claudino, MD has received a total of $29,178 in payments from pharmaceutical and medical device companies, with $1,073 received in 2024. These payments were reported across 871 transactions from 81 companies. The most common payment nature is "Food and Beverage" ($16,300).

As a Medicare-enrolled provider, Claudino has provided services to 5,684 Medicare beneficiaries, totaling 10,969 services with total Medicare billing of $738,552. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Hematology, Hematology & Oncology
  • Location Paducah, KY
  • Active Since 07/21/2010
  • Last Updated 10/01/2024
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1588977391

Products in Payments

  • NINLARO (Drug) $3,982
  • LYNPARZA (Drug) $2,949
  • IMBRUVICA (Drug) $2,054
  • KEYTRUDA (Biological) $1,164
  • OPDIVO (Biological) $1,151
  • BRUKINSA (Drug) $778.72
  • LIBTAYO (Biological) $701.91
  • DARZALEX (Biological) $516.29
  • KISQALI (Drug) $339.30
  • ELITEK (Drug) $297.28
  • ZEJULA (Drug) $265.69
  • TECENTRIQ (Biological) $263.50
  • XTANDI (Drug) $256.40
  • Lenvima (Drug) $254.03
  • ENHERTU (Biological) $236.64
  • TAGRISSO (Drug) $230.73
  • Perjeta (Biological) $216.49
  • Imbruvica (Drug) $207.11
  • ERLEADA (Drug) $194.22
  • IMFINZI (Drug) $170.97

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Paducah